Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review - Poll - MDSpire

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review

  • By

  • Anvitha Nagaraj Sharma

  • Hima Bhagavatula

  • Michael T. Mapundu

  • Emile R. Chimusa

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review

  • by Anvitha Nagaraj Sharma, Hima Bhagavatula, Michael T. Mapundu, Emile R. Chimusa

  • July 1, 2026

Related Content

Bone health in neuroendocrine tumors and prognostic implications beyond skeletal metastases

Skin malformation assessment by triple wavelength imaging

Robot-assisted laparoscopic resection of giant pelvic solitary fibrous tumor: a case report with literature review